Wall Street rebounds as tech stocks surge, with the S&P 500 up 0.5% amid easing trade tensions and strong corporate earnings.

In a report released today, Chris Schott from J.P. Morgan maintained a Buy rating on Merck & Company (MRK – Research Report), with a price ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

In a report released yesterday, Mohit Bansal from Wells Fargo maintained a Hold rating on Merck & Company (MRK – Research Report), with a ...

Asian shares are trading mostly lower as markets mull the impact of tariffs being imposed by the United States and China ...

The stock markets in the US opened higher on February 4 as investors remained cautious about China’s stance on the Trump ...

Merck (MRK) stock sank like a stone on Tuesday after the pharmaceutical giant posted poor guidance for the rest of the year.

Merck’s MRK fourth-quarter revenue grew 7% to $15.6 billion (including Keytruda growth of 21% to $7.8 billion), in line with ...

The Dow Jones is hitting a comfortable midrange around 44,450 on Tuesday. Threats of nearly-global tariffs have evaporated ...

Merck's stock sank after the company reported fourth-quarter and year-end 2024 earnings this morning. Although it narrowly ...

Among active stocks, Estée Lauder ( EL) is the weakest stock in the S&P after the company’s downbeat outlook into the current fiscal quarter, along with plans to revive the business through job cuts ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...